Suchergebnisse - "Cubillo, Antonio"

PubPharm (7)

1

Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study

enthalten in: BMC cancer | 2024

von Elez, E. | Cubillo, A. | Alfonso, P. | +6

2

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE) : a phase 3 randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2019

von Merle, P. | Blanc, J. | Phelip, J. | +91

CommentIn: Lancet Gastroenterol Hepatol. 2019 Jun;4(6):418-420. - PMID 30954566

3

Quality of life in metastatic pancreatic cancer patients receiving liposomal irinotecan plus 5-fluorouracil and leucovorin

enthalten in: European journal of cancer (Oxford, England : 1990) | 2019

von Hubner, R. | Cubillo, A. | Blanc, J. | +10

4

Randomized, double-blind, phase two study of ruxolitinib plus regorafenib in patients with relapsed/refractory metastatic colorectal cancer

enthalten in: Cancer medicine | 2018

von Fogelman, D. | Cubillo, A. | García-Alfonso, P. | +12

5

Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-EGFR Therapy and Molecularly Selected by Circulating Tumor DNA Analyses : A Phase 2 Randomized Clinical Trial

enthalten in: JAMA oncology | 2018

von Montagut, C. | Argilés, G. | Ciardiello, F. | +29

ErratumIn: JAMA Oncol. 2019 May 1;5(5):745. - PMID 31070664

6

Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy : a Q-TWiST analysis

enthalten in: British journal of cancer | 2017

von Pelzer, U. | Blanc, J. | Melisi, D. | +11

7

Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1) : a global, randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2016

von Wang-Gillam, A. | Li, C. | Bodoky, G. | +79

CommentIn: Lancet. 2016 Feb 6;387(10018):507-8. - PMID 26616909

1
[1]